Vertex Pharmaceuticals Inc
VRTXHealth careStock · Data from SEC EDGAR 13F · Held by 15 of 87 tracked investors
Vertex Pharmaceuticals Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation48
- Growth75
- Profitability95
- Quality89
- Debt100
- Stability90
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 3 Aug 2026 | 4.20 | 4.15 | +1.2% |
| Mar 2026 | 4 May 2026 | 3.95 | 3.69 | +7.1% |
| Dec 2025 | 12 Feb 2026 | 4.65 | 4.40 | +5.7% |
| Sep 2025 | 3 Nov 2025 | 4.22 | 4.00 | +5.5% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart VRTX
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
15TB Tweedy Browne Tweedy, Browne Company | 1.51% |
GI Generali Investments CEE Generali Investments CEE | 0.25% |
JS Jim Simons Renaissance Technologies | 0.22% |
Čn Česká národní banka Česká národní banka | 0.2% |
Šn Švýcarská národní banka Swiss National Bank | 0.19% |
Ns Norský státní fond Norges Bank | 0.15% |
CA Cliff Asness AQR Capital Management | 0.11% |
IE Israel Englander Millennium Management | 0.08% |
KG Ken Griffin Citadel Advisors | 0.03% |
RD Ray Dalio Bridgewater Associates | 0.02% |
JG Joel Greenblatt Gotham Asset Management | 0.02% |
PT Paul Tudor Jones Tudor Investment Corp | 0.02% |
JY Jeff Yass Susquehanna International Group | 0.01% |
RB Ron Baron Baron Capital | 0% |
KF Ken Fisher Fisher Investments | 0% |
Frequently asked questions
How much is Vertex Pharmaceuticals Inc (VRTX) stock?
Vertex Pharmaceuticals Inc shares trade at $523.93, -2.10% over the last trading day. The price is delayed.
What is the market cap of Vertex Pharmaceuticals Inc?
The market cap of Vertex Pharmaceuticals Inc is about $133B and its price-to-earnings ratio (P/E) is 29.9.
How has Vertex Pharmaceuticals Inc stock performed over the last year?
The Vertex Pharmaceuticals Inc share price changed by +24.33% over 12 months and by +183.31% over 5 years.
Which big investors hold Vertex Pharmaceuticals Inc?
According to the latest 13F filings, 15 of 87 tracked investors hold Vertex Pharmaceuticals Inc, for example Tweedy Browne, Generali Investments CEE, Jim Simons.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.